Michele R. Wing

3.5k total citations · 1 hit paper
34 papers, 2.5k citations indexed

About

Michele R. Wing is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Michele R. Wing has authored 34 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Michele R. Wing's work include Protein Kinase Regulation and GTPase Signaling (10 papers), Fibroblast Growth Factor Research (8 papers) and Cancer Genomics and Diagnostics (8 papers). Michele R. Wing is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (10 papers), Fibroblast Growth Factor Research (8 papers) and Cancer Genomics and Diagnostics (8 papers). Michele R. Wing collaborates with scholars based in United States, Switzerland and Canada. Michele R. Wing's co-authors include Julie W. Reeser, Jharna Miya, Sameek Roychowdhury, Melanie A. Krook, Hui‐Zi Chen, Russell Bonneville, Lianbo Yu, Esko A. Kautto, T. Kendall Harden and John Sondek and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Michele R. Wing

33 papers receiving 2.4k citations

Hit Papers

Landscape of Microsatellite Instability Across 39 Cancer ... 2017 2026 2020 2023 2017 250 500 750 1000

Peers

Michele R. Wing
Cristina E. Tognon United States
Douglas I. Lin United States
Peter Würl Germany
Teijo Kuopio Finland
Ethan S. Sokol United States
Jeremy Clark United Kingdom
Cristina E. Tognon United States
Michele R. Wing
Citations per year, relative to Michele R. Wing Michele R. Wing (= 1×) peers Cristina E. Tognon

Countries citing papers authored by Michele R. Wing

Since Specialization
Citations

This map shows the geographic impact of Michele R. Wing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele R. Wing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele R. Wing more than expected).

Fields of papers citing papers by Michele R. Wing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele R. Wing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele R. Wing. The network helps show where Michele R. Wing may publish in the future.

Co-authorship network of co-authors of Michele R. Wing

This figure shows the co-authorship network connecting the top 25 collaborators of Michele R. Wing. A scholar is included among the top collaborators of Michele R. Wing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele R. Wing. Michele R. Wing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaffenberger, Benjamin H., Catherine Chung, Eric Samorodnitsky, et al.. (2024). Myeloid neoplasm with histiocytosis and spleen tyrosine kinase fusion responds to fostamatinib. Haematologica. 109(11). 3816–3820. 1 indexed citations
2.
Chen, Hui‐Zi, Russell Bonneville, Julie W. Reeser, et al.. (2021). Genomic and Transcriptomic Characterization of Relapsed SCLC Through Rapid Research Autopsy. JTO Clinical and Research Reports. 2(4). 100164–100164. 13 indexed citations
3.
Krook, Melanie A., Max Wilberding, Kelly M. Bailey, et al.. (2020). Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion Cholangiocarcinoma. Molecular Cancer Therapeutics. 19(3). 847–857. 106 indexed citations
4.
Bonneville, Russell, Michele R. Wing, Melanie A. Krook, et al.. (2020). Characterization of Clonal Evolution in Microsatellite Unstable Metastatic Cancers through Multiregional Tumor Sequencing. Molecular Cancer Research. 19(3). 465–474. 7 indexed citations
5.
Krook, Melanie A., Hui‐Zi Chen, Julie W. Reeser, et al.. (2019). Characterization of a KLK2-FGFR2 fusion gene in two cases of metastatic prostate cancer. Prostate Cancer and Prostatic Diseases. 22(4). 624–632. 5 indexed citations
6.
Bonneville, Russell, Melanie A. Krook, Hui‐Zi Chen, et al.. (2019). Detection of Microsatellite Instability Biomarkers via Next-Generation Sequencing. Methods in molecular biology. 2055. 119–132. 53 indexed citations
7.
Krook, Melanie A., Russell Bonneville, Hui‐Zi Chen, et al.. (2019). Tumor heterogeneity and acquired drug resistance in FGFR2-fusion-positive cholangiocarcinoma through rapid research autopsy. Molecular Case Studies. 5(4). a004002–a004002. 63 indexed citations
8.
Datta, Jharna, Senthilkumar Damodaran, Jharna Miya, et al.. (2017). Akt Activation Mediates Acquired Resistance to Fibroblast Growth Factor Receptor Inhibitor BGJ398. Molecular Cancer Therapeutics. 16(4). 614–624. 72 indexed citations
9.
Hingorani, Pooja, Edoardo Missiaglia, Janet Shipley, et al.. (2015). Clinical Application of Prognostic Gene Expression Signature in Fusion Gene–Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group. Clinical Cancer Research. 21(20). 4733–4739. 17 indexed citations
10.
Samorodnitsky, Eric, Jharna Datta, Raffi Hagopian, et al.. (2014). Comparison of Custom Capture for Targeted Next-Generation DNA Sequencing. Journal of Molecular Diagnostics. 17(1). 64–75. 54 indexed citations
11.
Husain, Aliya N., David M. Parham, Timothy J. Triche, et al.. (2013). A Novel Algorithm for Simplification of Complex Gene Classifiers in Cancer. Cancer Research. 73(18). 5625–5632. 4 indexed citations
12.
Ji, Lingyun, Hiroyuki Shimada, Michele R. Wing, et al.. (2010). Current Treatment Protocols Have Eliminated the Prognostic Advantage of Type 1 Fusions in Ewing Sarcoma: A Report From the Children's Oncology Group. Journal of Clinical Oncology. 28(12). 1989–1994. 95 indexed citations
13.
Abdueva, Diana, et al.. (2010). Quantitative Expression Profiling in Formalin-Fixed Paraffin-Embedded Samples by Affymetrix Microarrays. Journal of Molecular Diagnostics. 12(4). 409–417. 75 indexed citations
14.
Bourdon, David, et al.. (2006). Quantification of Isozyme‐Specific Activation of Phospholipase C‐β2 by Rac GTPases and Phospholipase C‐ɛ by Rho GTPases in an Intact Cell Assay System. Methods in enzymology on CD-ROM/Methods in enzymology. 406. 489–499. 22 indexed citations
15.
Hains, Melinda D., Michele R. Wing, Savitri Maddileti, David P. Siderovski, & T. Kendall Harden. (2006). Gα12/13- and Rho-Dependent Activation of Phospholipase C-ϵ by Lysophosphatidic Acid and Thrombin Receptors. Molecular Pharmacology. 69(6). 2068–2075. 51 indexed citations
16.
Wing, Michele R., et al.. (2004). RhoA Activates Purified Phospholipase C-ϵ by a Guanine Nucleotide-dependent Mechanism. Journal of Biological Chemistry. 279(46). 47992–47997. 56 indexed citations
17.
Wing, Michele R., Jason T. Snyder, John Sondek, & T. Kendall Harden. (2003). Direct Activation of Phospholipase C-ϵ by Rho. Journal of Biological Chemistry. 278(42). 41253–41258. 93 indexed citations
18.
Wing, Michele R.. (2003). PLC- : A Shared Effector Protein in Ras-, Rho-, and G   -Mediated Signaling. Molecular Interventions. 3(5). 273–280. 116 indexed citations
19.
Wing, Michele R., et al.. (2001). Activation of Phospholipase C-ε by Heterotrimeric G Protein βγ-Subunits. Journal of Biological Chemistry. 276(51). 48257–48261. 79 indexed citations
20.
Blake, Bonita L., Michele R. Wing, Qiubo Lei, et al.. (2001). Gβ Association and Effector Interaction Selectivities of the Divergent Gγ Subunit Gγ13. Journal of Biological Chemistry. 276(52). 49267–49274. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026